- Report
- June 2024
- 200 Pages
Global
From €5437EUR$5,565USD£4,539GBP
€7768EUR$7,950USD£6,485GBP
- Report
- June 2024
- 200 Pages
Global
From €5437EUR$5,565USD£4,539GBP
€7768EUR$7,950USD£6,485GBP
- Report
- June 2024
- 200 Pages
Global
From €5437EUR$5,565USD£4,539GBP
€7768EUR$7,950USD£6,485GBP
- Report
- June 2024
- 200 Pages
Global
From €5437EUR$5,565USD£4,539GBP
€7768EUR$7,950USD£6,485GBP
- Clinical Trials
- June 2024
- 180 Pages
Global
From €1710EUR$1,750USD£1,427GBP
€2443EUR$2,500USD£2,039GBP
- Clinical Trials
- June 2024
- 240 Pages
Global
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €855EUR$875USD£714GBP
€1221EUR$1,250USD£1,020GBP
- Drug Pipelines
- April 2024
- 200 Pages
Global
From €1710EUR$1,750USD£1,427GBP
€2443EUR$2,500USD£2,039GBP
- Drug Pipelines
- April 2024
- 230 Pages
Global
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1368EUR$1,400USD£1,142GBP
€1954EUR$2,000USD£1,631GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €855EUR$875USD£714GBP
€1221EUR$1,250USD£1,020GBP
- Report
- April 2024
- 30 Pages
Global
From €2223EUR$2,275USD£1,856GBP
€3175EUR$3,250USD£2,651GBP
- Clinical Trials
- April 2024
- 210 Pages
Global
From €1710EUR$1,750USD£1,427GBP
€2443EUR$2,500USD£2,039GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1368EUR$1,400USD£1,142GBP
€1954EUR$2,000USD£1,631GBP
- Clinical Trials
- April 2024
- 180 Pages
Global
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1368EUR$1,400USD£1,142GBP
€1954EUR$2,000USD£1,631GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €855EUR$875USD£714GBP
€1221EUR$1,250USD£1,020GBP
- Report
- July 2024
- 132 Pages
Global
From €2443EUR$2,500USD£2,039GBP
- Report
- August 2024
- 163 Pages
Global
From €2443EUR$2,500USD£2,039GBP
- Report
- September 2024
- 200 Pages
Global
From €4884EUR$4,999USD£4,078GBP
The Liver Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat liver cancer. These drugs are used to reduce the size of tumors, reduce symptoms, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy.
Chemotherapy is a type of drug that works by killing cancer cells. Targeted therapy is a type of drug that works by targeting specific molecules in cancer cells. Immunotherapy is a type of drug that works by stimulating the body's own immune system to fight cancer.
The Liver Cancer Drugs market is highly competitive, with many companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly developing new drugs and treatments to improve the quality of life for those affected by liver cancer. Show Less Read more